Blended Solutions

Pharmaceutical sponsors need agile, adaptable outsourcing models that fit their evolving needs in a dynamic clinical research landscape marked by increasing complexity and costs. As sponsor strategies change, 91��ϡ�s blended solutions offer models that meet their clinical outsourcing needs.

Our outsourcing solutions

91�� offers blended solutions with custom configurations to meet sponsor challenges with seamlessly integrated services and structures designed for a holistic approach. With a single point of delivery, we combine FSP, FSO, standalone and specialty services to offer efficiency and control. Our expert consultants guide the transition and use formal governance to optimise the benefits from your bespoke, flexible and efficient model.

Our customisable models

Strategic/Functional model

Sponsors can utilise clinical FSP services or FSO services expanding to include tactical FSO, FSP or standalone services to complement delivery.

Enterprise model

91�� seamlessly migrates resources across a range of model types (FSO + FSP + Standalone) to support the entire enterprise with integrated services.

Transformative model

Sponsor needs evolve over time. This model allows sponsors to direct which model to use depending on their required level of control (i.e., core/non-core assets).

Benefits of blended solutions

Tailored solutions and services anchored in a consultative pharmaceutical partnership with 91�� experts benefits sponsors through:

Aligning on shared objectives and flexibility to support shifting priorities
Improving operational efficiencies from accelerated startup timelines
Increased control over core and non-core assets
Cost-effective solutions for near- and long-term strategies
Robust change management and consultative relationships

Whitepaper: Embracing a blended operating model

Maximising efficiency and flexibility with custom outsourcing.

Read whitepaper

155 biopharma leaders were interviewed, and key takeaways show:

40% currently use a blended solution
63% report reduced trial times using blended solutions
72% expect to adopt a more flexible outsourcing model in the next 5 years.

Observations in outsourcing: Survey results show a blended future

Discover the trends in modern clinical development outsourcing across biopharmaceutical organisations.

Download the survey report

Featured case studies

Elevating biopharma R&D through multifaceted support in strategic partnerships

Read our case study to learn more about the way we supported our biopharma partner with an FSP model across multiple service areas, in addition to a Full Service partnership.

Blended solution gives emerging pharma greater control with expert support

Learn how an emerging pharma company was supported by a blended solution to give them greater control

Partnership model evolutions for Top 10 pharma partner

Read about the ways in which a blended model has benefited a top 10 pharma partner as their organisation has evolved

Strategic blended solutions for enterprise efficiency

Read our case study to learn how a blended solution has helped minimise operational costs whilst increasing control and flexbility

Explore our full library of Blended Solutions case studies to learn more about how we have increased operating efficiencies for our clients.

All case studies

91��

Our outsourcing solutions